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Abstract
The aim of this paper is the presentation of recent advancements in impedance cardiography
regarding methodical approach, applied equipment and clinical or research implementations.
The review is limited to the papers which were published over last 17 months (dated 2011 and
2012) in well recognised scientific journals. (Cardiol J 2012; 19, 5: 550–556)
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Introduction
Stroke volume (SV) is one of the important he-
modynamic parameters characterizing mechanical
activity of the heart working as a pump. However it
is not very often used by the clinicians. The accu-
rate measurement could be performed invasively (at
some risk) but when noninvasive methods are used
clinicians have limited confidence in them. During
the routine echocardiography examination the ejec-
tion fraction, cardiac contractility and the size of heart
chambers are determined. But the volume of blood
ejected during one cycle or over a minute is not very
often evaluated, unless a research study is per-
formed. SV and its changes in response to physio-
logical tests or pharmacological stimuli are potential-
ly an excellent tool for evaluation of the mechanical
efficiency of the heart. Additionally, reliable mea-
surement of SV during transient events (e.g. in atri-
al fibrillation or in the presence of extrasystole) could
allow quantitative estimation of cardiac work when
it is difficult or even impossible to apply other, well-
established, “classical” methods.
Limitation of the review
During the period of interest (2011–2012) there
were published 99 papers listed in Web of Science
(Thomson-Reuters science citation database) under
the key word “impedance cardiography”. In this
review we decided to analyze only those published
in the regular journals of high impact factor (exclud-
ing supplements and conference papers) which
seemed to us the most important from the methodo-
logical or application points of view (n = 22). Among
those 99 papers some were published on intratho-
racic impedance technique but we did not focus on
them in this review.
Impedance cardiography:
The method foundations
Impedance cardiography signal generation
Impedance cardiography (ICG) is a diagnostic
method based on measurement of the electrical
properties of the biological tissues applied to the
thorax region. The most popular method of gene-
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rating the ICG signal uses 4-electrode (tetrapolar)
topology, when the application electrodes and re-
ceiving are separated. Figure 1 presents the scheme
of the tetrapolar impedance measurement. The con-
stant amplitude current oscillates between the ap-
plication electrodes (A) and the voltage changes are
detected on the receiving electrodes (R). This volt-
age due to the constant amplitude of current is pro-
portional to the impedance of the tissue segment
limited by the band electrodes. The voltage chang-
es, are proportional to the impedance changes be-
tween receiving electrodes. Please note the dis-
tance between inner — receiving electrodes is de-
scribed as L0. The ECG electrodes are not
presented. In some systems the same electrodes
are used for detecting ECG and generating ICG sig-
nal. In several papers the mixed topology of the spot
electrodes substituting band electrodes is used.
Impedance cardiography traces
The typical ICG traces with simultaneously
obtained one lead of ECG are presented on Figure 2.
On the first channel from the top ECG is shown, on
the second the first derivative of the impendance
changes signal which is denoted dz/dt. In practice
only ECG and the first derivative signal (dz/dt) are
used to calculate the hemodynamic parameters.
Another data essential to make those evaluations is
the value of the base impedance (Z0), which is usu-
ally not changing very fast. So in some applications
Z0 was stored as a only one value for several cycles.
The formulas for stroke volume calculation
There are several different methods of calcu-
lation a SV and other hemodynamic parameters
using impedance signal. These differences are the
consequence of the different models used in de-
scribing the electrical properties of human chest.
Generally, all methods base on the characteristic
points on the impedance waveform and parameters
describing the physical dimension of the analysed
part of the chest. Unfortunately, the usage of the
different formulas may result in different values and
different correlation with the reference methods.
From the historical point of view the first who
related the SV and the impedance changes was
Kubicek [1, 2], who based on Nyboer works [3, 4].
His remains the most often used in the research for
impedance cardiography:
SV = r × L02× Z0–2×(dz/dt)max  × ET
where, SV — stroke volume [cm3], r — blood re-
sistivity [W × cm]; L0 — distance between recei-
ving electrodes [cm]; Z0 — basic impedance of the
body segment limited by receiving electrodes [W],
(dz/dt)max — the maximum of the first derivative of
the impedance signal [W/s]; ET — ejection time [s],
time of blood ejection from the left chamber, deter-
mined by selection of characteristic points on
(dz/dt) trace.
There were also other formulas: introduced by
Sramek, Bernstein and Osypka or the formulas ap-
plied by the producers of Task Force Monitor or
PhysioFlow which were described in the second
part of the monograph on Ambulatory Impedance
Cardiography [5]. Most of them are based on the
so called “volume of electrically participating tis-
sues” which describes the cone (or truncated cone)
of the chest. The formulas applied by the produc-
ers of the equipment are usually not fully disclosed.
Figure 1. The scheme of the tetrapolar impedance me-
asurement. Figure 2. The typical impedance cardiography traces:
the changes in the dz/dt (first derivative of the DZ) si-
gnal denoted as dz/dt (2nd channel), recorded simulta-
neously with one lead of ECG (1st channel). Please note
the way of determination of PEP, ET (LVET) and (dz/
/dt)max, here marked as ”amp”.
A1
A2
R1
R2
Q ECG
amp
ICG
ETPEP
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The model
One of the main problems regarding the ICG
methodology is the lack of the proper model de-
scribing the origin of ICG traces. Despite some
computer modelling of the impact of the organs on
impedance signal it is still difficult to find the for-
mula for SV calculations which will give the accept-
ed accuracy regardless the condition of a patient.
Thus, there are formulas using simplified cylindri-
cal or the trunked cone models or some formulas
which are not fully revealed to the public (created
by the producers of the equipment).
Rozenman et al. [6] mentioned in the letter to
the Editor of “International Journal of Cardiology”
about their earlier reports on methods and equip-
ment which could be easily used to screen patients
with left ventricular systolic dysfunction. They pro-
posed a new index for detecting left ventricular
systolic dysfunction. The index (Granoy Goor In-
dex — GGI) combines systolic time interval and
some impedance parameters derived from ICG sig-
nals. This index may be described as a product of
(relative change in impedance, heart rate [HR] and
time from R-ECG to the peak of impedance signal
which they named a: GGI = (DR/R)× a× HR. They
proved that for GGI cutoff value of 10 the sensiti-
vity, specificity positive and negative predictive va-
lues are 86%, 100%, 100% and 96%, respectively,
which were better than for any other parameters
derived from ICG signals. The new index shows
a tendency to abandon the usage of geometrical
values (distance between the electrodes) or the
body characterizing parameters (weight, height,
body surface area etc.) in creating the dimension-
less index describing cardiac performance. It is nor-
malized change of impedance times the normalized
time of the peak impedance. However, the task of
calculating SV without geometrical and/or body pa-
rameters is still to be reached.
Kuang et al. [7] performed a decomposition of
the impedance signal to find the impact of the im-
pedance change components of the blood vessels
and ventricles in thorax from the mixed impedance
signals detected on the chest surface. They extract-
ed five components causing the change of the im-
pendance: for the aorta, blood vessel in left lung,
blood vessel in right lung, left ventricle, and right
ventricle. Their experiments show that the wave-
form graphs of various components correspond with
the physiological activities of the heart and blood
vessels in a cardiac cycle. Also the main waveform
of the ventricular components of left ventricle and
right ventricle is contrary to that of the vascular
components (from aorta, and both pulmonary ves-
sels), and the negative peak point of the waveform
graphs of both ventricles are in phase with the se-
cond cardiac sound. Moreover, the results obtained
in 80 normal adults show that the amplitude of aor-
tic component is the largest and that left and right
pulmonary vessels are the intermediate, while the
components from left and right ventricles are the
smallest. Their experiments confirmed the results
obtained from mathematical modeling.
In another paper from that group [8] they pro-
posed new equation based on a parallel impedance
model different from Nyboer’s equation is deduced.
It was verified with the experiments in 100 healthy
adults. Their equation shows that the thoracic im-
pedance change (DZ) is directly proportional to the
value of the volume change (DV) of the blood ves-
sel, to the ratio of the basic impedance to the body
height (Z0/H), while it is inversely proportional to
the square of the chest circumference (C–2).
Validity of ICG
Although the method was many times verified
using invasive and noninvasive methods which was
recently summarized in the forth chapter of the
monograph [5] the new papers appear showing the
validation of the method in a particular physiologi-
cal/clinical stress/test or when the particular equip-
ment from a producer (who offers a special formula
for SV calculations) is used.
Limper et al. [9] performed the study with the
following aims: 1) to determine cardiac output (CO)
by inert gas rebreathing (IGR) {CO(reb)} during
transition into 0 G, in the standing position; and 2)
to compare ICG and pulse contour method (PCM)
with CO(reb) as a reference method. They mea-
sured baseline CO(reb) and HR on the ground, and
CO(reb), CO(pcm), CO(icg) and HR in standing and
supine positions in the transition to weightlessness
in six subjects. The Bland and Altman analysis, and
analysis of percentage error of each data set showed
showed poor agreement for CO(pcm), and CO(icg)
compared to CO(reb). They suggested that large
bias for both comparisons indicated that both PCM
and ICG underestimate the true CO value. Also they
observed that paired CO values of individual sub-
jects showed a better correlation between methods
and a broad bias range, indicating a preponderant
role for large between-subjects variability. They did
not exclude ICG measurement to track CO dyna-
mics during rapid changes of acceleration profiles,
however suggested a repeated CO(reb) determina-
tions for calibration in 1G acceleration.
Petter et al. [10] compared the non-invasive
thoracic electrical bioimpedance Aesculon tech-
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nique {TEB(Aesculon)} with thermodilution (TD)
to evaluate whether TEB(Aesculon) may offer
a reliable means for estimating CO in humans. They
performed their study in 33 patients, with a mean
age 59 ± 2.7 years, that underwent right heart cathe-
terization for clinical investigation of pulmonary
hypertension or severe heart failure. According to
their report CO measured with TEB(Aesculon) cor-
relate poorly with CO obtained by TD at rest (r =
= 0.46, p < 0.001), during exercise (r = 0.35,
p < 0.013) and NO inhalation (r = 0.41, p < 0.017).
CO was higher for TEB(Aesculon) than TD with
0.86 ± 0.14 L/min at rest (p < 0.001) and 2.95 ±
± 0.69 L/min during exercise (p < 0.003), but simi-
lar during NO inhalation, with a tendency (p < 0.079) to
be 0.44 ± 0.19 L/min higher for TEB(Aesculon)
than TD. TEB(Aesculon) overestimated CO com-
pared to TD with ~17% at rest and ~34% during
exercise, but the techniques showed similar results
during NO inhalation. Finally they concluded that
TEB(Aesculon) may at present not replace TD for
reliable CO measurements in humans.
Osbak et al. [11] performed the comparison
between CO values obtained in 127 atrial fibrilla-
tion patients and in 24 with sinus rhythm using IGR
device and ICG system against echocardiography,
as reference. They noticed that IGR showed larger
intra-patient variation than ICG (0.11 vs. 0.054).
Also, they observed that ICG and IGR both under-
estimated CO compared to echocardiography. They
also found that variation between the IGR and the
reference method for atrial fibrillation patients was
less than desired. Finally they concluded that ICG
was superior to IGR and showed acceptable agree-
ment with echocardiography and variability similar
to echocardiography. Since this study was performed
in one body position this last conclusion seems to
have some limitations.
The similar study of a comparative evaluation of
electrical velocimetry and IGR was published by
Trinkmann et al. [12]. They wanted to evaluate wheth-
er hemodynamic parameters calculated using an algo-
rithm (electrical velocimetry) proposed by Osypka and
Bernstein [13] and implemented in thoracic electri-
cal bioimpedance Aesculon device {TEB(Aesculon)}
can be used interchangeably with IGR parameters in
the clinical setting. They found an acceptable agree-
ment between IGR and ICG as well as a high repro-
ducibility, which was significantly higher for ICG.
They noted that for CO values exceeding the physiolo-
gical range a statistically significant difference was ob-
served. Thus in conclusion they stated that values of
cardiac function determined by either method should
not be used interchangeably in the clinical setting.
An interesting study was performed by Tom-
sin et al. [14] on diurnal and position-induced varia-
bility of ICG measurements in healthy subjects.
They concluded that in healthy subjects under stan-
dardized conditions, reproducibility of means of
multiple ICG measurements is high for most of the
indices based on SV and CO. However, knowing the
natural variation of those indices they were not able
to draw conclusions on trends in diseased subjects.
Tonelli et al. [15] tried to evaluate the accura-
cy and precision of ICG (PhysioFlow PF-05) as
a method for noninvasive hemodynamic monitoring
of patients with pulmonary hypertension. They per-
formed a prospective and blinded study of patients
who underwent right heart catheterization. They
noted that in patients with pulmonary hypertension
ICG had good accuracy and fair precision for CO
determination when compared with thermodilution.
In conclusion, they stated that ICG may provide
information about the preload status and has the
potential to become a cost-effective and noninva-
sive method for the follow-up of patients with pul-
monary hypertension.
Also Taylor et al., [16] used PhysioFlow to
evaluate the measurement of cardiac output ob-
tained by continuous electrical bioimpedance car-
diography to compare with a simultaneous direct
Fick measurement of CO in children with conge-
nital heart disease. In conclusion of their study per-
formed on 56 patients they said that compared with
measurements made by direct Fick method, CO
measured using the PhysioFlow device was unre-
liable in anesthetized children with congenital heart
disease.
It seems that in children impedance method
creates some problems with accurate measurement
of hemodynamic parameters. Ballestero et al. [17]
using another device (Nicom) noted that the CI
measured by bioreactance in children (with no he-
modynamic disturbances) varies with the age and
weight of the patients and is lower than the normal
range in a large percentage of measurements. They
concluded that this method is not useful for evalu-
ating CI in small children. However, the most im-
portant limitation of their study was the lack of com-
parison between the cardiac values obtained with
bioreactance and those obtained using other refe-
rence methods. They only characterized the inter-
nal consistency of the results, their correlation with
age and body characterizing indices.
Certainly, the above papers showed some lim-
itations of the method. In our opinion, until the
model and formula derived from the model does not
properly reflect the mechanics of the circulation in
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the chest we should only use the impedance results
in test when the patient is the reference for him-
self and avoid the comparisons of the result between
the patients. In many cases observing trends and
reactions to the tests provide clinically useful in-
formation about the cardiovascular dynamics.
Research and clinical applications
We presented below several applications of
ICG which, according to our opinion, could be used
in the future, despite the methodological uncertain-
ties. In those applications patient remains the re-
ference for himself and the immediate changes or
short-term or long-term trends might be observed.
Also some negative experiences with ICG applica-
tion were reviewed.
Postural stress
The application of ICG may be useful for ex-
planation of orthostatic syncope mechanism. Tah-
vanainen et al. [18] thanks to the application of ICG
observed a major decrease in systemic vascular
resistance in subjects with presyncope during
0.25 mg nitroglycerin-stimulated tilt-table test, in
the absence of changes in cardiac output. These
findings indicated that even a small dose of nitro-
glycerin significantly decreased arterial resistance
and cardiac afterload.
In the paper of Limper et al. [9] mentioned in
the earlier section they found that ICG could be
used (in limited form) for monitoring the hemody-
namic response to the acceleration stress.
DeMarzo [19] noticed that hypertensive pa-
tients have diverse cardiovascular abnormalities
that can be quantified by ICG. He tried to show how
ICG waveform analysis with postural change can be
used to detect subclinical cardiovascular disease in
patients with high blood pressure. He suggested
that by stratifying patients with ventricular, vascu-
lar, and hemodynamic abnormalities, treatment
could be customized basing on the abnormal under-
lying mechanisms with the potential to rapidly con-
trol blood pressure, prevent progression of cardio-
vascular disease, and possibly reverse remodeling.
Cardiac rehabilitation
It seems that ICG could be the useful method
in quantitative monitoring of cardiac rehabilitation
process. Gielerak at al. [20] studied the effects of
cardiac rehabilitation on hemodynamic parameters
measured by ICG in 50 patients with heart failure
(NYHA class II and III, left ventricular ejection frac-
tion £ 40%) who underwent 8-week cardiac reha-
bilitation program. They performed clinical and
hemodynamic assessment before and after cardiac
rehabilitation and noticed that ICG revealed a sig-
nificant change in diastolic to systolic wave ratio and
a significant change in the hemodynamic profile of
the left ventricular blood ejection. This findings lead
them to conclude that ICG revealed beneficial ef-
fects of cardiac rehabilitation, manifested by re-
duced fluid retention and a reduced effect of pre-
load on left ventricular relaxation and ejection.
Pacemaker optimization
Inappropriate programming of the atrio-ven-
tricular delay (AVd) decreases cardiac output sig-
nificantly. ICG could be used in quantitative evalu-
ation of the optimal settings for the pacemakers.
Khan et al. [21] used ICG cardiac output mea-
surement (NICOM) for optimization of cardiac re-
synchronization therapy (CRT) devices. They com-
pared the effect of NICOM-based optimization to no
optimization (empiric settings) on CRT outcomes
in 203 patients divided into several groups. The
empiric group (n = 54) was programmed to “out of
the box” settings with a fixed AVd of 120 ms and
a VV delay of 0 ms; and the optimization group
(n = 149) underwent adjustments of both the AV
and VV delays according to the greatest improve-
ment in resting CO. In their study the primary end-
points were improvements in left ventricular vo-
lumes and function from baseline at 6 months. Sec-
ondary endpoints were change in NYHA class,
quality of life score, and 6-min walk test perfor-
mance. They concluded that device optimization
using noninvasive measures of CO is associated
with better clinical and echocardiographic response
compared to empiric settings.
Sleep studies
Impairment of autonomic nervous system dy-
namics may result in cardiovascular activity disor-
ders. Balachandran et al. [22] used heart rate vari-
ability (HRV) and pre-ejection period (PEP) derived
from ICG traces, to estimate autonomic activity. The
hypothesis of their study was that even in a cohort
of patients with mild, asymptomatic obstructive sleep
apnoea without overt cardiovascular disease, daytime
HRV metrics and ICG measurements of pre-ejection
period would demonstrate increased sympathetic
and decreased parasympathetic modulation com-
pared to matched controls. They used PEP since it
has been previously noted to correlate with cardiac
sympathetic tone. However in their study, the pre-
sence of obstructive sleep apnoea was not associated
with a significant change in PEP.
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De Zambotti et al. [23] intended to compare car-
diovascular and autonomic responses before and
after falling asleep in eight insomniacs and eight nor-
mal sleepers. They obtained HR, SV, CO and PEP by
ICG during a night of polysomnographic recording.
They found the decrements in HR and CO and
increases in SV in both groups after sleep onset
compared with wakefulness. However, PEP (relat-
ed inversely to sympathetic beta-adrenergic acti-
vity) showed increases after sleep onset in controls,
but remained unchanged in insomniacs. PEP was
also significantly lower in insomniacs than in nor-
mal sleepers in both conditions.
Pregnancy monitoring
Moertl et al. [24] intended to evaluate ICG
derived SV and CO reliability during pregnancy.
They determined thoracic impedance Z0, left ven-
tricular ejection time and the maximum value of the
first derivative of the impedance waveform (dZ/
/dt)(max) beat-to-beat. They noticed that the two
main components of non-invasive SV estimation,
left ventricular ejection time and (dZ/dt)(max), de-
creased in week 35 relative to week 12 by 7.6% ±
± 4.8% and by 36.0% ± 14.0%, respectively, based
on a decrease in R-R interval of 9.9% ± 9.7%,
whereas changes in Z0 did not play a significant role.
Furthermore, the decrease of (dZ/dt)(max) was great-
er in the third compared to the second trimester of
pregnancy. Taking into account an 18.2% ± 6.8% body
weight increase, the calculated SV decreased in week
35 relative to week 12 by 19.2% ± 14.3%. The nor-
malized term ((dZ/dt)(max))/Z(0) explained 85–94%
of the variance of SV change after week 20. These
results were confirmed for fixed R-R interval at
a constant value across the repeated measurements.
Based on beat-to-beat analysis of the main compo-
nents of non-invasive SV estimation by ICG, mea-
sured repeatedly throughout normal pregnancy, they
concluded that SV calculations render invalid data.
Their findings strongly suggest that CO cannot be
reliably assessed with ICG in pregnant women.
However, San-Frutos et al. [25] used ICG to
monitor hemodynamic changes during pregnancy
and postpartum in 18 subjects from 12th week of
gestation until 6th month of postpartum period. They
observed statistically significant decrease in end-
-diastolic volume, SV, CO and ejection fraction un-
til 48 h after delivery. They concluded that ICG may
be the most appropriate and accurate technique to
measure normal hemodynamic changes during
pregnancy and postpartum.
Tomsin et al. [26] tried to evaluate pulse tran-
sit time (PTT), equivalent to pulse wave velocity, as
the time interval between corresponding characte-
ristics of electrocardiography and Doppler waves,
corrected for HR, at the level of renal interlobar
veins, hepatic veins, and arcuate branches of uterine
arteries. They also used ICG to measure PTT at the
level of the thoracic aorta. In normal pregnancy, all
PTT increased gradually (p £ 0.01). PTT was short-
er in late-onset preeclampsia (p < 0.05) and also in
early-onset preeclampsia, with exception for hepa-
tic veins and thoracic aorta (p > 0.05). Their results
indicated that PTT is an easy and highly accessible
measure for vascular reactivity in both arterial and
venous sites of the circulation. Their observations
correlate well with known gestational cardiovascu-
lar adaptation mechanisms. This lead them to con-
clusion that PTT could be used as a new parameter
in the evaluation and prediction of preeclampsia.
Holter-type monitoring of
impedance cardiography signals
Another field of the possible applications of ICG
measurements seems to be associated with the
ambulatory, Holter type recordings of the signal,
which was explored in the first monograph on that
matter [5]. Some possible clinical applications, such
as monitoring of hemodynamics in cardiac arrhyth-
mia, pacemaker optimisation or control (e.g. pace-
maker syndrome) were discussed in the chapter 5
of that monograph [5]. Others, including monitor-
ing of dynamics of pharmacological treatment (ino-
tropic, chronotropic or antihypertensive) are also
suggested there.
There are several Holter-type systems for
monitoring central hemodynamics available for re-
search applications. In December 2010, one of them,
received Food and Drug Administration  clearance
which might help in bringing the method to the clin-
ical practice, but probably will not finish the discus-
sion about the reliability of ICG. Thus technically,
ambulatory monitoring of ICG signals is possible.
Is it possible to introduce non-invasive ambulatory
hemodynamic monitoring to clinical practice? In our
opinion the non-invasive, Holter-type ambulatory
hemodynamic monitoring can yield additional quan-
titative data that are useful in clinical practice. How-
ever final decision will be undertaken by the clini-
cians who spot the benefit from using the method
to the patients.
Conclusions and prospects
for impedance cardiography
The controversies around the verification of
ICG resulted in a sceptical approach by health au-
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thorities to this technique. However, since July 1st,
1999, Medicare and Medicaid Services decided to
allows limited coverage of cardiac monitoring us-
ing electrical bioimpedance. They also issued the
list of applications excluded from reimbursement,
which reflects inadequacy of that method in parti-
cular clinical situation. Thus, not covered is the use
of such a device for any monitoring of patients with
proven or suspected disease involving severe re-
gurgitation of the aorta, or for patients with minute
ventilation sensor function pacemakers, since the
device may adversely affect the functioning of that
type of pacemaker. Moreover, these devices do not
render accurate measurements in cardiac bypass
patients when they are on a cardiopulmonary by-
pass machine though they do provide accurate mea-
surements prior to and post bypass pump. Their
detailed description may be found at http://
new.cms.hhs.gov/manuals/downloads/Pub06_
PART_50. pdf. Following the decision of Medicare
and Mediaid Services in USA the respective national
health institutions in other countries decided to al-
low refunding the ICG diagnosis, initially in a very
limited areas, e.g. Intensive Care Units only (e.g.
in Poland, since 2010). Certainly, these decisions
could stimulate the producers of the ICG equipment
and affect the development of the hemodynamic
monitoring systems in both, stationary and ambu-
latory, versions.
Simultaneous recording of both ECG and a sig-
nal that reflects central hemodynamics activity
might provide additional diagnostic data. It appears
that electrical ICG, a simple method that allows for
continuous, noninvasive determination of SV, max-
imum velocity of ejection and systolic time inter-
vals, could be used to supply such a signal for sta-
tionary and ambulatory applications [11, 12]. How-
ever, the standardisation of the electrodes
topography and the measurement procedure is
highly needed.
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